Chronic Kidney Disease (CKD) Market was valued at USD 15.5 Billion in 2022 and is projected to reach USD 22.3 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030.
The Chronic Kidney Disease (CKD) market was valued at approximately USD 12.8 billion in 2022. It is projected to experience a compound annual growth rate (CAGR) of 7.5% from 2022 to 2027. This growth is driven by the increasing prevalence of CKD due to factors such as rising incidences of diabetes and hypertension, as well as an aging global population. Additionally, advancements in medical technology, including improved diagnostic tools and innovative treatment options, are expected to contribute significantly to the market's expansion. The rising awareness and proactive management of CKD, coupled with government initiatives and increased healthcare spending, further fuel market growth.
Opportunity analysis reveals substantial potential in emerging markets where healthcare infrastructure improvements are underway. The growing adoption of renal replacement therapies, including dialysis and kidney transplants, is anticipated to create significant market opportunities. Furthermore, the increasing focus on personalized medicine and the development of novel pharmacological agents offer promising avenues for growth. In particular, the Asia-Pacific region and Latin America present notable opportunities due to their large patient populations and expanding healthcare facilities. Investments in research and development, along with collaborations between healthcare providers and stakeholders, are likely to drive future market advancements.
Get an In-Depth Research Analysis of the Global Chronic Kidney Disease (CKD) Market Size And Forecast [2025-2032]
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Chronic Kidney Disease (CKD) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Chronic Kidney Disease (CKD) Market
Hospitals
Specialty Clinics
Based on Types the Market is categorized into Below types that held the largest Chronic Kidney Disease (CKD) market share In 2023.
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Chronic Kidney Disease (CKD) Market Research Analysis
1. Introduction of the Global Chronic Kidney Disease (CKD) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Chronic Kidney Disease (CKD) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Chronic Kidney Disease (CKD) Market, By Type
6. Global Chronic Kidney Disease (CKD) Market, By Application
7. Global Chronic Kidney Disease (CKD) Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Chronic Kidney Disease (CKD) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/